Habit-forming drugs in Hyderabad are bringing attention to a public-health problem that cannot be addressed only through raids on medical shops. A report by Telangana Today says enforcement agencies have found discrepancies at 406 shops during recent statewide special drives, while psychiatrists and health advocates are calling for stronger rehabilitation services and greater attention to the psychological pressures behind medicine misuse.
The concern is unfolding across Hyderabad and other urban areas of Telangana. The reported enforcement activity covers locations including Charminar, Mehdipatnam, Tolichowki, Malakpet, Saroornagar, Balapur, Hayathnagar, Secunderabad and Amberpet. These locations indicate that the issue is not confined to one neighbourhood or a single type of settlement. It is appearing across a spread of established city areas and expanding urban zones where medical retail, dense populations and vulnerable communities intersect.
The central distinction is between medicines that require prescriptions and medicines that carry a risk of dependence. The report notes that not all prescription medicines are addictive. Antibiotics and medicines used for conditions such as high blood pressure generally do not cause addiction. Some medicines, however, can create chemical dependence, tolerance and severe psychological or physical addiction when used regularly, without supervision or for purposes other than treatment.
Certain dependence-prone medicines are regulated under Schedule H1 and Schedule X of the Drugs Rules. The report identifies opioid painkillers such as tramadol and tapentadol, nerve-pain medicines such as pregabalin, central nervous system depressants including alprazolam, zolpidem and nitrazepam, and codeine-based cough syrups among the medicines that can be misused. Depending on the medicine and how it is consumed, these drugs may produce euphoria, sedation or pain relief, creating the possibility that therapeutic products will be used as substitutes for other substances.
This is where the urban character of the problem becomes important. A medicine may enter the city through a regulated retail system, but its misuse is shaped by conditions outside the shop. The source report describes self-medication and the search for a quick response to stress as possible starting points. Once repeated use develops into physical dependence or psychological distress, the problem moves beyond the question of whether a retailer followed prescription rules. It becomes a question of whether the city has sufficient medical, psychiatric and rehabilitation support for people who need help.
Dr Vishal Akula, senior psychiatrist and professor and head of psychiatry at Government Medical College, Nizamabad, told Telangana Today that what begins as self-medication or a quick fix for stress can escalate into physical dependence, psychological distress and potentially life-threatening overdoses. His assessment places the enforcement issue within a clinical pathway: access and misuse may be the first visible stages, but dependence and overdose are the more serious consequences.
The 406 shops identified during the special drives provide an important measure of enforcement activity, but they do not by themselves measure the full scale of addiction. The figure records discrepancies detected by agencies during inspections; it does not establish how many people are dependent on habit-forming medicines, how many have suffered overdoses, or how many require rehabilitation. Those distinctions matter because enforcement data and public-health data answer different questions.
Inspection findings can show where regulatory controls may have failed or where authorities found reasons to act. They cannot, without additional health data, show the prevalence of misuse across the population. Similarly, the presence of seizures, raids or show-cause notices demonstrates official action, but not whether people who lose access to one medicine receive treatment or shift to another substance. The supplied report does not provide figures for dependence, admissions, overdoses, rehabilitation capacity or treatment outcomes.
That absence does not reduce the importance of the enforcement figure. It shows instead that the state is currently seeing the problem most clearly through the regulatory system. Drug inspectors can identify sales irregularities and act against medical shops. Health services must identify dependence, manage withdrawal, treat psychological distress and support recovery. These are related responsibilities, but they are not interchangeable.
The regulatory framework also makes the institutional division visible. Medical shops are part of the medicine-supply chain, while drug inspectors are responsible for detecting violations and enforcing rules. Psychiatrists and rehabilitation providers operate within the health system. Families, patients and neighbourhoods encounter the consequences when the regulatory and treatment sides do not connect. A raid may restrict supply at one outlet, but it cannot on its own diagnose dependence or provide continuing care.
The report says enforcement agencies have intensified activity through raids, decoy operations and show-cause notices. Such measures are aimed at illegal or irregular supply and are a necessary part of controlling medicines with dependence potential. But health advocates quoted in the report argue that restricting retail access is only part of the response. They want rehabilitation services to be expanded and psychological pressures to be addressed.
This points to a two-part policy landscape. The first part is control: prescriptions, inspections, action against violations and monitoring of medicines regulated under Schedule H1 and Schedule X. The second is care: access to psychiatric services, rehabilitation and support for people whose use has moved from experimentation or self-medication to dependence. The report provides evidence of the first part through the statewide drives, but does not establish the scale or distribution of the second.
For a city such as Hyderabad, the treatment question has a practical geographic dimension. Enforcement activity has been reported in multiple parts of the metropolitan area, from the Old City and central neighbourhoods to western, southern and northern locations. If problematic use is similarly spread, a treatment response concentrated in one institution or one part of the city may not be accessible to all affected residents. The source material does not identify the location or capacity of rehabilitation services, making that an important unanswered administrative question rather than a fact that can be assumed.
The same caution applies to the reasons people misuse these medicines. The report refers to vulnerable populations, chemical dependency, recreational escape, self-medication and psychological pressure. These descriptions identify possible pathways, but they do not establish a single cause. Nor does the supplied evidence quantify the role of stress, unemployment, social isolation, untreated mental-health conditions, affordability or availability. Any policy response therefore needs to distinguish between what enforcement records show and what patient-level health information may reveal.
The urban system also needs a clearer way to measure outcomes. The available figure of 406 shops is an activity indicator: it tells readers how many outlets reportedly showed discrepancies during the drives. A fuller public-health picture would require other measures, including referrals for treatment, rehabilitation access, overdose response, repeat cases and the continuity of care after a person is identified. None of those figures is supplied in the report, so the extent to which enforcement is reducing harm remains unestablished.
The bigger urban question is whether medicine regulation and addiction treatment are being treated as separate problems when they are connected in people’s lives. A person may first appear in a regulatory record through a retailer, but later require psychiatric care or rehabilitation. A family may experience the issue as a behavioural or financial crisis rather than as a breach of medicine rules. A neighbourhood may see repeated enforcement without knowing whether treatment is available nearby. These different viewpoints describe one system from different points within it.
The evidence currently confirms three things: authorities are conducting special drives, discrepancies have reportedly been found at 406 shops, and professionals are warning that medicine misuse can develop into dependence and serious harm. It does not yet establish the prevalence of addiction in Hyderabad, the number of affected residents, the adequacy of rehabilitation capacity or the results of the enforcement campaign. Those are the measures that will determine whether the response is moving from detection to durable public-health intervention.
